Category: GENETICS - Page 15 - Start Medical Product Development

Piccolo Medical, Inc. Receives FDA Clearance for 2nd Generation SmartPICC® technology

July 16, 2025

SAN FRANCISCO, July 16, 2025 /PRNewswire/ — Piccolo Medical, Inc. (Piccolo), a leading innovator in vascular access technology, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its next-generation SmartPICC® Stylet and PM2+™ System. This significant achievement marks a major leap forward in safe, efficient, and cost-effective peripherally inserted central catheter (PICC) placement, offering enhanced benefits for both patients and healthcare providers.

RIVANNA’s next-generation ultrasound guidance platform and AI-driven imaging software receive FDA 510(k) clearance

July 16, 2025

CHARLOTTESVILLE, Va., July 16, 2025 /PRNewswire/ — RIVANNA®, developers of world-first imaging-based medical technologies, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) regarding the Accuro® 3S diagnostic ultrasound system and SpineNav-AI™ image processing software. This clearance authorizes the use of both technologies in United States hospital and clinical settings, providing anatomical guidance during needle or catheter placement.

New gene tool leads to better treatments for complex diseases

July 15, 2025

Genetic changes can signal evidence of disease, but pinpointing which genes and what’s changed can be difficult.

AI-powered ‘digital twin’ created to predict personal health outcomes

July 15, 2025

Recently, researchers from Prof. Eran Segal’s laboratory at the Weizmann Institute of Science have harnessed artificial intelligence to create a personalized “digital twin” that allows them to detect a risk of developing diseases, initiate preventive treatment and even run simulations to predict which treatment will be most effective.

Seegene Launches STAgora™ Platform to Transform Infectious Disease Surveillance

July 7, 2025

AI-powered system integrates real-time PCR data for nationwide pathogen tracking, enabling faster public health responses and smarter diagnostic strategies.

Virtual reality software uncovers new details in pediatric heart tumors

July 1, 2025

New cutting-edge software developed in Melbourne can help uncover how the most common heart tumor in children forms and changes. And the technology has the potential to further our understanding of other childhood diseases, according to a new study.

New method combines imaging and sequencing to study gene function in intact tissue

June 30, 2025

The approach collects multiple types of imaging and sequencing data from the same cells, leading to new insights into mouse liver biology.

Genomics software processes datasets 100 times faster than current tools to advance cancer research

June 27, 2025

A new tool—seen as the Google Earth for genomics—will transform how scientists visualize and analyze genomic data, advancing cancer research techniques.

STENTiT enrolls first patient in trial of regenerative stent system

June 27, 2025

STENTiT has implanted its Resorbable Fibrillated Scaffold in the first patient enrolled in the VITAL-IT 1 study evaluating the device for chronic limb-threatening ischemia (CLTI) below the knee.

Saliva analysis could reveal risk of developing cancer, heart disease or Parkinson’s using molecular markers

June 26, 2025

A research team led by the University of the Basque Country has identified hundreds of molecular markers in saliva that could reveal the risk of a person developing major diseases such as cancer, cardiovascular diseases, diabetes and neurodegenerative diseases. Their results, published in npj Genomic Medicine, lay the foundation for the development of a powerful, non-invasive tool for early diagnosis and precision medicine.

Blog

- GENETICS